Metabolism and proliferation share common regulatory pathways in cancer cells.
Cancer development involves major alterations in cells' metabolism. Enhanced glycolysis and de novo fatty acids synthesis are indeed characteristic features of cancer. Cell proliferation and metabolism are tightly linked cellular processes. Others and we have previously shown a close relationship between metabolic responses and proliferative stimuli. In addition to trigger proliferative and survival signaling pathways, most oncoproteins also trigger metabolic changes to transform the cell. We present herein the view that participation of cell-cycle regulators and oncogenic proteins to cancer development extend beyond the control of cell proliferation, and discuss how these new functions may be implicated in metabolic alterations concomitant to the pathogenesis of human cancers.
Fritz
V
V
Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.
Fajas
L
L
D000818:Animals; D002453:Cell Cycle / Q000502:physiology; D049109:Cell Proliferation; D006801:Humans; D050356:Lipid Metabolism / Q000502:physiology; D008954:Models, Biological; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology* / Q000503:physiopathology; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology*; D014157:Transcription Factors / Q000378:metabolism / Q000502:physiology
D014157:Transcription Factors